Back to XERS
Cambridge Investment Research Advisors, Inc. → XERS
Cambridge Investment Research Advisors, Inc. XERS Position History
Xeris Biopharma Holdings, Inc. • Healthcare
Quarters held
6
Latest value
$385K
Q3 2026
Peak value
$385K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $282K |
| Q4 2025 | $272K |
| Q1 2026 | $201K |
| Q2 2026 | $320K |
| Q2 2026 | $320K |
| Q3 2026 | $385K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $385K | 40.3K | — | — |
| Q2 2026 | $320K | 40.4K | — | — |
| Q2 2026 | $320K | 40.4K | — | — |
| Q1 2026 | $201K | 34.7K | — | — |
| Q4 2025 | $272K | 34.6K | — | — |
| Q3 2025 | $282K | 34.6K | — | — |